Trials / Unknown
UnknownNCT04273763
Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Second Affiliated Hospital of Wenzhou Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Compare the efficacy and safety of Bromhexine Hydrochloride Tablets combined with standard treatment/ standard treatment in patients with suspected and mild, or common novel coronavirus pneumonia (COVID-19). Random, open, group sequential design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bromhexine Hydrochloride Tablets | Bromhexine Hydrochloride Tablets |
| DRUG | Arbidol Hydrochloride Granules | Standard treatment refers to the latest edition of Pneumonia Diagnosis and Treatment Scheme for Novel Coronavirus Infection. Arbidol Hydrochloride Granules is recommended but not enforced to use. |
| DRUG | Recombinant Human Interferon α2b Spray | Standard treatment refers to the latest edition of Pneumonia Diagnosis and Treatment Scheme for Novel Coronavirus Infection. |
Timeline
- Start date
- 2020-02-16
- Primary completion
- 2020-05-10
- Completion
- 2020-06-01
- First posted
- 2020-02-18
- Last updated
- 2020-05-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04273763. Inclusion in this directory is not an endorsement.